Cargando…
The cost‐effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity
BACKGROUND: The Food and Drug Administration has approved several pharmacotherapies for the treatment of obesity. This study assesses the cost‐effectiveness of six pharmacotherapies and lifestyle intervention for people with mild obesity (body mass indices [BMIs] 30 to 35). METHODS: A microsimulatio...
Autores principales: | Lee, Minyi, Lauren, Brianna N., Zhan, Tiannan, Choi, Jin, Klebanoff, Matthew, Abu Dayyeh, Barham, Taveras, Elsie M., Corey, Kathleen, Kaplan, Lee, Hur, Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156872/ https://www.ncbi.nlm.nih.gov/pubmed/32313674 http://dx.doi.org/10.1002/osp4.390 |
Ejemplares similares
-
Estimated Cost-effectiveness of Medical Therapy, Sleeve Gastrectomy, and Gastric Bypass in Patients With Severe Obesity and Type 2 Diabetes
por: Lauren, Brianna N., et al.
Publicado: (2022) -
Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents
por: Lim, Francesca, et al.
Publicado: (2023) -
Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis
por: Klebanoff, Matthew J., et al.
Publicado: (2019) -
Cost-Effectiveness of Pharmacotherapy to Reduce Obesity
por: Veerman, J. Lennert, et al.
Publicado: (2011) -
Pharmacotherapy for Obesity
por: Joo, Jong Kil, et al.
Publicado: (2014)